Human Papillomavirus Vaccination
Conditions
Keywords
Human papillomavirus, Vaccination, Text message, SMS, mHealth, Uganda
Brief summary
This RCT will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic in Kampala. The investigators will assess the impact of vaccine text message and automated phone reminders on human papillomavirus (HPV) vaccination initiation and completion.
Detailed description
Cervical cancer is the leading female cancer in Uganda. HPV is the principal cause of cervical cancer. The national HPV vaccination program in Uganda includes preteen/ adolescent girls. Vaccinations are provided within schools or through community health centers. However, in Kampala, HPV vaccination especially series completion is low. While research regarding the use of text message vaccine reminders is strong in the U.S., their use has not been demonstrated in a preteen/adolescent population in Sub-Saharan Africa and other low and middle income countries (LMICs) in a full RCT. In this study, RCT caregivers of preteens/adolescents will be randomized and stratified by site, language and HPV vaccine dose needed (initiation vs. completion). Intervention families will receive text message or automated phone reminders based on family preference.
Interventions
BEHAVIORALText Message/automated phone reminder
Receipt of text message or automated phone reminders notifying when the next HPV vaccine dose is due (either first or second)
Sponsors
Makerere University
National Cancer Institute (NCI)
Columbia University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
10 Years to 14 Years
Healthy volunteers
No
Inclusion criteria
* Be a parenting adult of an adolescent girl aged 10-14 years * Reside in Kampala and/or the surrounding districts * Speak English or Luganda * Have a cell phone with text messaging capability * Must have ability to consent
Exclusion criteria
* Parenting adult speaks other language than English or Luganda only * Parenting adult already enrolled in the study for another child * Participation in previous HPV vaccine reminder study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time to Receipt of First HPV Vaccine Dose | 12 months | Timeliness of vaccination (time to event) will be measured |
| Time to Receipt of Second HPV Vaccine Dose | 12 months | Timeliness of vaccination (time to event) will be measured |
Countries
Uganda, United States
Outcome results
None listed